Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
Clinical and Applied Thrombosis/Hemostasis · 2023
DOI: 10.1177/10760296221151166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, 2023. Verfasst von Edgar Hernández-Zamora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine, 61663Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra (INR-LGII), México City, México. Hauptthemen laut MEDLINE: Legg-Calve-Perthes Disease, Hemostatics, Thrombophilia, Blood Coagulation Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Legg–Calvé–Perthes disease (LCPD) is a pediatric disorder that occurs due to the avascular necrosis of the femoral head and affects the range of motion of the hip in various degrees. Its etiology is still unknown, although it has been associated with coagulation abnormalities, however, the lack of reproducibility in the results in various studies has created a controversy as to whether hemostasis disorders are related to LCPD. On the other hand, there is little information on laboratory studies that could facilitate the diagnosis and treatment of LCPD.
Methods
Blood and plasma samples were tested from 25 patients with LCPD and 50 healthy controls, matched by sex and age. Cellular markers were evaluated through complete blood count, as well as coagulation times, coagulation factors activity, antithrombotic proteins, and homocysteine concentration.
Results
After assessing activity value frequencies in each group, the results showed more significant activity in some of the biological risk markers of thrombophilia, presenting a substantial difference in prothrombin time↘, FV↗, FVIII↗, FIX↗, and Hcy↗. These values imply that there may be hypercoagulable states in patients, which can cause thrombotic events.
Conclusions
Diminished prothrombin time and increase in FV activity, FVIII, FIX, and Hcy concentration support the hypothesis that microthrombi formation in small-caliber vessels could be causing avascularity and femoral necrosis, which are traits of LCPD. In addition, based on our results, we believe that the laboratory studies carried out are very useful in the diagnosis and treatment of LCPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Medicine, 61663Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra (INR-LGII), México City, México.
- Morphology Department, Escuela Nacional de Ciencias Biológicas, 27740Instituto Politécnico Nacional (ENCB, IPN), México City, México.
- Clinical Neurosciences, INR-LGII, México City, México.
- Pathology Central Laboratory, INR-LGII, México City, México.
ORCID-Profile: Armando Odiseo Rodríguez-Olivas
Zitieren
APA
Hernández-Zamora, E., Rodríguez-Olivas, A. O., Rosales-Cruz, E., Galicia-Alvarado, M. A., Zavala-Hernández, C., & Reyes-Maldonado, E. (2023). Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease. Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/10760296221151166
Vancouver
Hernández-Zamora E, Rodríguez-Olivas AO, Rosales-Cruz E, Galicia-Alvarado MA, Zavala-Hernández C, Reyes-Maldonado E. Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease. Clinical and Applied Thrombosis/Hemostasis. 2023. doi:10.1177/10760296221151166
BibTeX
@article{HernndezZamora2023,
author = {Hernández-Zamora, Edgar and Rodríguez-Olivas, Armando Odiseo and Rosales-Cruz, Erika and Galicia-Alvarado, Marlene Alejandra and Zavala-Hernández, Cesar and Reyes-Maldonado, Elba},
title = {Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2023},
doi = {10.1177/10760296221151166}
}
EUVIMED